Perspective Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
/ 
Frequently asked questions
To buy Perspective Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Perspective Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Perspective Therapeutics Inc. is CATX:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Perspective Therapeutics Inc. has its primary listing on NYSE American. You can trade Perspective Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Perspective Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Perspective Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Perspective Therapeutics Inc..